NCT02978586View on ClinicalTrials.gov

A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

October 25, 2019

Study Completion Date

October 25, 2019

Conditions
Prostate-specific Membrane Antigen Positive TumorsProstate CancerBreast CancerLung Cancer
Interventions
DEVICE

[Ga-68]PSMA PET/MR

All participants will undergo at least 1 baseline \[Ga-68\]PSMA PET/MR. If participants test positive for \[Ga-68\]PSMA tumor uptake, they will under up to 2 additional scans

Trial Locations (1)

44106-5065

University Hospitals, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT02978586 - A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors | Biotech Hunter | Biotech Hunter